Mod GRF(1-29), often known as CJC without DAC, is a CJC peptide designed for precise work on growth hormone pathways. Researchers value this compound because it acts as a stable analogue of Growth Hormone Releasing Hormone. It contains four targeted substitutions that increase structural stability and improve reliability in controlled studies. As a result, scientists can run detailed experiments on GHRH activity with clearer timing and more repeatable outcomes.
This CJC peptide plays an important role in projects that explore pituitary signaling and GH-pulse patterns. Its short activity window gives researchers tight control over stimulation events. Unlike CJC-1295 with DAC, Mod GRF(1-29) does not bind to albumin. Therefore, its effects remain brief, predictable, and easy to measure. This quality makes it ideal for studies that require fast signaling, transient receptor interaction, or high-frequency sampling.
Researchers often buy Mod GRF(1-29) for tasks such as:
Tracking pulsatile GHRH activity over short timeframes
Examining receptor behavior during rapid stimulation
Comparing long-acting and short-acting GHRH analogues
Analysing GH-pulse frequency in isolated models
Because of its stability and precision, this CJC peptide supports a wide range of hormone-pathway investigations. It suits studies that need accurate timing, consistent dosing, and rapid data collection. Our Mod GRF(1-29) arrives as a high-purity laboratory reagent intended for qualified research environments only. It does not serve any clinical or therapeutic purpose.
For research use only. Not for human consumption.
Not a researcher? Exit
